top
Search terms
Results 1 - 10 of 21 - ordered by :
Pages: 1 2 3
Ehjournal

The causality of plasma low-density lipoprotein-cholesterol (LDL-C) and reduced LDL receptor-mediated LDL uptake in the pathophysiology of ASCVD has been established beyond any reasonable doubt.3 For ...

European Heart Journal, Landmesser, Ulf, John Chapman, M., Farnier, Michel, Gencer, Baris, Gielen, Stephan, Hovingh, G. Kees, Lüscher, Thomas F., Sinning, David, Tokgözoğlu, Lale, Wiklund, ...

Date : 08/03/2017 Item size : 424498 bytes
Ehjournal

Heart failure increasingly not only accounts for a significant part of cardiovascular morbidity and mortality, but is also responsible for many hospitalizations as outlined again in the most recent ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/02/2017
Ehjournal

The causality of plasma low-density lipoprotein-cholesterol (LDL-C) and reduced LDL receptor-mediated LDL uptake in the pathophysiology of ASCVD has been established beyond any reasonable doubt.3 For ...

European Heart Journal, Landmesser, Ulf, John Chapman, M., Farnier, Michel, Gencer, Baris, Gielen, Stephan, Hovingh, G. Kees, Lüscher, Thomas F., Sinning, David, Tokgözoğlu, Lale, Wiklund, ...

Date : 09/03/2017
Ehjournal

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of drugs able to decrease LDL-C by 5070% when administered either as a monotherapy or on a background with statins.46 ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/09/2015
Ehjournal

Initially, it allowed us to use the position of stars and planetary motion for navigation and the discovery of new continents; next, it set the basis for the development of engines and technologies; ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/11/2013 Item size : 374557 bytes
Ehjournal

[...]important questions on how to optimally treat certain patient groups remain unanswered. The objective of this current opinion article is to explore how therapeutic scientific research and ...

European Heart Journal, Jukema, J. Wouter, Brouwer, Judith R., Lüscher, Thomas F., Engberts, Dick P., Quax, Paul H.A.

Date : 21/10/2015 Item size : 150534 bytes
Ehjournal

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast New therapies in cardiovascular disease are best evaluated with outcome trials comparing event rates between a new therapy and ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/09/2015 Item size : 193609 bytes
Ehjournal

All other measures may then be seen as surrogate endpoints or surrogates. [...]even serious events such as myocardial infarction and stroke may be considered surrogates, as their effect is to ...

European Heart Journal, Weintraub, William S., Lüscher, Thomas F., Pocock, Stuart

Date : 01/09/2015 Item size : 406663 bytes
Ehjournal

Initially, it allowed us to use the position of stars and planetary motion for navigation and the discovery of new continents; next, it set the basis for the development of engines and technologies; ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/11/2013
Ehjournal

Heart failure increasingly not only accounts for a significant part of cardiovascular morbidity and mortality, but is also responsible for many hospitalizations as outlined again in the most recent ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/02/2017 Item size : 104441 bytes